Skip to main content

Tilray Brands Inc(TLRY-T)
TSX

Today's Change
Real-Time Last Update
Day Low9.35
Day High9.79
Open:9.61
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change

Top Stories: Tilray Brands Inc

Select a category then submit the form to load news
GlobeNewswire
Tilray Medical, CC Pharma, and 14U Pharma Announce Strategic Alliance with “gesund leben” Cooperation and Alliance Healthcare Deutschland to Accelerate Market Expansion and Strengthen Pharmacy Access Across Germany
GlobeNewswire
Lighter. Cheaper. Funner. Pub Light Is Here.
Baystreet
Stocks in play: Tilray Brands, Inc.
GlobeNewswire
Tilray Brands Acquires BrewDog Australia, Establishing Strategic Base to Accelerate Global Beverage and Consumer Products Growth Across the Asia-Pacific Region
GlobeNewswire
Tilray Brands Acquires BrewDog, a Leading Global Craft Brand, Creating a ~$500 Million Global Craft Beer and Beverage Platform
GlobeNewswire
Good Supply Cannabis Brand Expands High-Potency Portfolio with New Spring Lineup Across Canada
Baystreet
Stocks in play: Tilray Brands, Inc.
GlobeNewswire
Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership
Baystreet
Stocks in play: Tilray Brands, Inc.
GlobeNewswire
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals
Baystreet
Stocks in play: Tilray Brands, Inc.
GlobeNewswire
Breckenridge Distillery Appoints Romano Beverage for Distribution in Illinois
GlobeNewswire
Tilray’s CC Pharma Recognized as a TOP 100 Innovator in Germany
Baystreet
Stocks in play: Tilray Brands, Inc.
GlobeNewswire
Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced
GlobeNewswire
Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted in Music, Art and Craft Beer Culture
Stock Target Advisor
Tilray Brands Inc. (TLRY:CA) Canaccord Genuity Maintains “Hold” Rating
Tilray Brands Inc. (TLRY:CA) Canaccord Genuity Maintains “Hold” Rating
GlobeNewswire
SweetWater 420 Fest Unveils Powerhouse 2026 Lineup: Umphrey’s McGee, Thievery Corporation & Chromeo to Headline
Baystreet
Stocks in play: Tilray Brands, Inc.
GlobeNewswire
SweetWater Introduces Big Trip Double IPA: A Bold New Craft Beer
GlobeNewswire
Tilray Medical Strengthens Italian Market Presence with the Launch of Tilray Medical Italia and Expanded Medical Cannabis Portfolio
Baystreet
Gains Highlight TSX’s Last Session
GlobeNewswire
Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance
Baystreet
Stocks in play: Tilray Brands, Inc.
GlobeNewswire
Tilray Brands Expands Dry January Offerings with Zero-Proof Spirits, Non-Alcoholic Beers and Hemp-Derived THC Beverages
Baystreet
Stocks in play: Tilray Brands, Inc.
GlobeNewswire
Enhance Your Dry January with Mindful Sipping: Try Tilray’s Mollo and XMG Cannabis Beverages
Baystreet
Stocks in play: Tilray Brands, Inc.
GlobeNewswire
Tilray Brands to Announce Second Quarter Fiscal Year 2026 Financial Results on January 8, 2026
GlobeNewswire
Tilray Accelerates U.S. Medical Cannabis Expansion After Landmark Federal Rescheduling: Launches Tilray Medical USA to Lead Nationwide Medical Cannabis Innovation and Growth
Baystreet
TSX Starts Day up 250+
The Globe and Mail
Stock market today: Global stocks stabilize ahead of big central bank decisions, key data
The Toronto Stock Exchange Broadcast Centre is shown in Toronto on June 28, 2013. THE CANADIAN PRESS/Aaron Vincent Elkaim

Profile

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.